Saratov JOURNAL of Medical and Scientific Research

Role of melatonin in pathogenesis of age-related macular degeneration

Year: 2019, volume 15 Issue: №2 Pages: 559-563
Heading: Ophtalmology Article type: Review
Authors: Khodzhaev N.S., Chuprov A.D., Kim S.M.
Organization: The S. Fyodorov Eye Microsurgery Federal State Institution

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in people aged 50 years and older in the advanced world. The article deals with the epidemiology and pathogenesis of the disease. Special attention is given to a new approach to the prevention and treatment of AMD with the help of melatonin; modern management options and scientifc achievements are discussed. Many researchers have shown that melatonin is able to protect retinal epithelial cells from oxidative damage. Perhaps the physiological reduction of melatonin in the elderly may be an important factor in the dysfunction of the retinal pigment epithelium, which is the cause of AMD.

1 Gheorghe A, Mahdi L, Musat O. Age-related macular degeneration. Romanian Journal of Ophthalmology 2015; 59 (2): 74–7
2 Iroku-Malize T, Kirsch S. Eye Conditions in Older Adults: Age-Related Macular Degeneration. FP Essent 2016; 445: 24–8
3 Cheung LK, Eaton A. Age-related macular degeneration. Pharmacotherapy 2013; 33 (8): 838–55 4 World Health Organization WHO 2016 URL: t / bulletin / volumes / 96 / ru / (20 March 2019)
5 Flaxman SR, Bourne RR, Resnikof S, et al. Global causes of blindness and distance vision impairment 1990– 2020: a systematic review and meta-analysis. Lancet Global Health 2017; 5 (12): 1221–34
6 Bikbov MM, Faizrakhmanov RR, Yarmukhametova AL. Age-related macular degeneration. Moscow: Aprel, 2013; 196 p.
7 Lim SL, Mitchell P, Seddon JM, et al. Age-related macular degeneration. The Lancet 2012; 379 (9827): 1728–38
8 Machalińska A. Age-related macular degeneration as a local manifestation of atherosclerosis: a novel insight into pathogenesis. Klinika Oczna 2013; 115 (1): 74–8
9 He MS, Chang FL, Lin HZ. The Association between Diabetes and Age-Related Macular Degeneration among the Elderly in Taiwan. Diabetes Care 2018 2018; 41 (10): 2202–11
10 Cougnard-Grégoire A, Delyfer MN, Korobelnik JF, et al. Elevated high-density lipoprotein cholesterol and age- related macular degeneration: the Alienor study. Public Library of Science. PLoS One 2014; 9 (3): e90973
11 Fischer T. The age-related macular degeneration as a vascular disease / part of systemic vasculopathy: contributions to its pathogenesis. Orvosi Hetilap 2015; 156 (9): 358–65
12 Kessel L, Erngaard D, Flesner J, et al. Cataract surgery and age-related macular degeneration: An evidence- based update. Acta Ophthalmologica 2015; 93 (7): 593–600
13 Zak PP, Yegorova TS, Rozenblym YuZ, et al. Spectral vision correction: scientifc background and practicalapplications. Moscow: Nauchniy mir, 2005; 192 p.
14 Casparis H, Lindsley K, Kuo IC, et al. Surgery for cataracts in people with age-related macular degeneration. Cochrane Database Syst Rev 2017; (6): CD006757
15 Ho J, Xirasagar S, Kao LT, et al. Neovascular age-related macular degeneration is associated with cataract surgery. Acta Ophthalmologica 2018; 96 (2): 213–7
16 Baatz H, Darawsha R, Ackermann H, et al. Phacoemulsifcation does not induce neovascular age-related macular degeneration. Investigative Ophthalmology & Visual Science 2008; 49 (3): 1079–83
17 Grixti A, Papavasileiou E, Cortis D, et al. Phacoemulsifcation surgery in eyes with neovascular age-related macular degeneration. ISRN Ophthalmology 2014: 417603
18 Huynh N, Nicholson BP, Agrón E, et al. Visual Acuity after Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2; Report No. 5 Ophthalmology 2014; 121 (6): 1229–36
19 Kubicka-Trząska A, Karska-Basta I, Romanowska-Dixon B. Current concepts in pathogenesis of age-related macular degeneration. Klinika Oczna 2014; 116 (4): 277–82
20 O'Connell E, Neelam K, Nolan J, et al. Macular carotenoids and age-related maculopathy. Annals Academy of Medicine Singapore 2006; 35 (1): 821–30
21 Alpatov SA, Shchuko AG. Age-related macular degeneration. Moscow: GEOTAR-Media, 2015; 176 p.
22 Feher J, Kovacs I, Artico M et al. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiology of Aging 2006; 27 (7): 983–993
23 Nassar K, Grisanti S, Elfar E, et al. Serum cytokines as biomarkers for age-related macular degeneration. Graefe»s Archive for Clinical and Experimental Ophthalmology 2015; 253 (5): 699–704
24 Cao S, Ashley Ko, Partanen M, et al. Relationship between systemic cytokines and complement factor HY402H polymorphism in patients with dry age-related macular degeneration. Am J Ophthalmology 2013; 156 (6): 1176–838
25 Stefanova NA, Zhdankina AA, Fursova AZh, et al. Potential of melatonin for prevention of age-related macular degeneration: experimental study. Advances in Gerontology 2013; 26 (1): 122–9
26 Rastmanesh R. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity. Medical Hypotheses 2011; 76 (1): 79–85
27 Bardak H, Uğuz AC, Bardak Y. Protective efects of melatonin and memantine in human retinal pigment epithelium (ARPE-19) cells against 2-ethylpyridine-induced oxidative stress: implications for age-related macular degeneration. Cutaneous and Ocular Toxicology 2018; 37 (2): 112–20
28 Wiechmann AF, Summers JA. Circadian rhythms in the eye: the physiological signifcance of melatonin receptors in ocular tissues. Progress in Retinal and Eye Research 2008; 27 (2): 137–60
29 Argun M, Tok L, Uguz AC. Melatonin and amfenac modulate calcium entry, apoptosis, and oxidative stress in ARPE-19 cell culture exposed to blue light irradiation (405 nm). Eye (Lond) 2014; 28 (6): 752–60
30 Claustrat B, Leston J. Melatonin: physiological efects in humans. Neuro-Chirurgie 2015; 61 (2-3):77–84
31 Pozdeev NV. On the role of melatonin and dopamine in the regulation of circadian rhythms of the retina of the rat: PhD abstract. St. Petersburg, 1999; 32 p.
32 Alarma-Estrany P, Pintor J. Melatonin receptors in the eye: location, second messengers and role in ocular physiology. Pharmacol Ther 2007; 113 (3): 507–22
33 Hoyle CHV, Peral A, Pintor J. Melatonin potentiates tear secretion induced by diadenosine tetraphosphate in the rabbit. Eur J Pharmacol 2006; 552 (1-3): 159–61
34 Carracedo G, Carpena C, Concepción P, et al. Presence of melatonin inhuman tears. Journal of Optometry 2017; 10 (1): 3–4
35 Zawilska J. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the goose pineal gland, retina, and plasma. Gen Comp Endocrinol 2003; 134 (3): 296– 302
36 Arushanjan JeB, Ovanesov KB. The importance of melatonin for the physiology and pathology of the eye. Medical Bulletin of the North Caucasus 2016; 1 (11): 126–33
37 Arushanyan EB. Anti-infammatory activity of melatonin and glucocorticoid hormones. Medical Bulletin of the North Caucasus 2013; 4 (8): 99–104
38 Chesnokova NB, Beznos OV, Beyshenova GA. The infuence of melatonin and dexamethasone instillations on the clinical course of uveitis and the biochemical processes in the aqueous humour of the anterior chamber of the eye (an experimental study). Russian Pediatric Ophthalmology 2016; 1 (11): 29–34
39 Zakharova VV. The role of mitochondria in endothelial barrier function impairment caused by tumor necrosis factor: PhD abstract. Moscow, 2016; 22 p.
40 Kaur C, Sivakumar V, Robinson R, et al. Neuroprotective efect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats. J Pineal Res 2012; 54 (2):190–206
41 Park SY, Jang WJ, Yi EY, et al. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res 2010; 48 (2): 178–84
42 Yi C, Pan X, Yan H, et al. Efects of melatonin in age-related macular degeneration. Ann NY Acad Sci 2005; 1057: 384–92
43 Blasiak J, Reiter RJ, Kaarniranta K. Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration. Oxid Med Cell Longev 2016; 2016: 6819736
44 Sande PH, Álvarez J, Calcagno J, et al. Preliminary fndings on the efect of melatonin on the clinical outcome of cataract surgery in dogs. Veterinary ophthalmology 2016; 19 (3): 184–94.

2019_02-1_559-563.pdf285.23 KB

No votes yet